Newly released federal records reveal treatment delays, questionable coverage decisions, and serious oversight problems in Medicare’s controversial AI-assisted authorization experiment.

For millions of older Americans, Medicare represents the assurance that necessary medical care will be available when they need it. But a federal experiment involving artificial intelligence is raising an unsettling question: What happens when a technology company becomes an additional gatekeeper between patients and their doctors?

Newly released government records reveal serious problems in a Medicare pilot program designed to use artificial intelligence and other technologies to review requests for certain medical treatments. The documents describe delayed decisions, questionable rejections, malfunctioning computer systems, and confusion among the private companies responsible for administering the program.

The findings, obtained through litigation by the Electronic Frontier Foundation (EFF), raise concerns about the federal government’s growing reliance on automated systems in decisions that can directly affect patients’ health.

What Is Medicare’s AI Experiment?

The program, called the Wasteful and Inappropriate Service Reduction Model, or WISeR, began in January 2026. It operates in six states: Arizona, New Jersey, Ohio, Oklahoma, Texas, and Washington.

Unlike Medicare Advantage, where private insurers have long used prior authorization requirements, WISeR introduces additional medical reviews for selected services under Original Medicare.

The program covers certain procedures and treatments, including some pain-management injections, implanted nerve stimulators, skin and tissue substitutes, and selected orthopedic procedures.

Under WISeR, participating technology companies use artificial intelligence and other software tools to help evaluate whether requested services meet Medicare’s existing coverage requirements. A licensed clinician must review any recommendation not to approve a request.

The Centers for Medicare & Medicaid Services (CMS) says the objective is to prevent unnecessary or potentially harmful procedures, reduce wasteful spending, and make the review process more efficient.

But documents obtained by EFF suggest that the program’s early implementation fell considerably short of those ambitions.

Federal Records Reveal a Troubled Rollout

In October, EFF released more than 800 additional pages of government records documenting problems during WISeR’s first months.

The records include correspondence between CMS and four participating technology companies. Federal officials questioned delays in processing requests, potentially inaccurate decisions, technical failures, and inadequate responses to healthcare providers.

In Washington state, CMS raised concerns about Virtix Health, the company responsible for the program there. A March letter identified problems that included decisions taking longer than permitted, questionable determinations, delays in issuing tracking numbers, and difficulties obtaining assistance.

Virtix attributed some of the problems to incomplete documentation, confusion among medical providers, and the challenges of processing large numbers of requests during the program’s launch.

In Ohio, another contractor, Innovaccer, had warned federal officials before implementation that its electronic system would not be fully ready. The government nevertheless proceeded with the original timetable. CMS subsequently demanded corrective action.

Similar concerns emerged involving contractors in New Jersey and Arizona.

These were not merely abstract software problems. For patients waiting for medical procedures, administrative delays could translate into prolonged pain, uncertainty, and postponed treatment.

When a Delayed Decision Becomes

, , , , , , , , , , , , ,
You may be interested in
Latest Posts from

Leave a Reply

Your email address will not be published. Required fields are marked *